Neutralization sites on swine vesicular disease virus (SVDV) have been identified by sequence analysis of neutralization-resistant mutants. Eight neutralizing monoclonal antibodies (MAbs) were produced and neutralization-resistant mutants were selected with the MAbs. Resistance of the mutants to neutralization was shown using the stab-neutralization method, and the results indicated the presence of five neutralization sites on the virus. The location of each site was identified from amino acid changes resulting from nucleotide substitutions in the mutants, and designated site 1 (residues 87 and 88 ofVP1), 2a (residue 163 ofVP2), 2b (residue 154 ofVP2), 3a (residues 272 and 275 of VP1, 60 of VP3) and 3b (residues 70 and 233 of VP2, 73 and 76 of VP3). The locations of the amino acid substitutions at each site formed a cluster on a computer-simulated three-dimensional model of SVDV and were exposed to the surface of the virion.
Introduction
Swine vesicular disease (SVD) was first observed in Italy in 1966 (Nardelli et al., 1968) . Since then, outbreaks have been reported in several countries in Europe and Asia (UK, France, Poland, Austria, Germany, Switzerland, Japan, Hong Kong, Malta and Greece; Graves, 1986) . SVD is an infectious disease of pigs characterized by the appearance of vesicles on the tongue, in the mouth and on the feet and hocks; these lesion are indistinguishable from those caused by foot-and-mouth disease virus (FMDV) .
The causative agent, SVD virus (SVDV) belongs to the genus enterovirus of the Picornaviridae; it is considered a monotype according to cross-neutralization tests. Common antigenic characteristics between SVDV and coxsackievirus B5 (CB5) have been reported (Graves, 1973) . It has also been reported that SVDV is distinguishable from CB5 by cross-neutralization and immunodiffusion tests (Brown et al., 1973 (Brown et al., , 1976 . However, the antigenic sites have not been located for either SVDV or CB5. The complete nucleotide sequence of SVDV has been determined for the strains H/3'76 (Inoue et al., 1989) , J1'73 (Inoue et al., 1993) and UKG/27/72 (Seechurn et al., 1990) , and high sequence similarity (> 98 %) exists between them.
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In picornaviruses such as poliovirus, rhinovirus and FMDV, the detailed antigenic structure has been intensively studied using neutralizing monoclonal antibodies (MAbs) and neutralization-resistant escape mutants (Sherry & Rueckert, 1985; Crowther et al., 1993) . In poliovirus, which belongs to the same genus as SVDV, the neutralization epitopes were shown to cluster in five distinct neutralization sites (site 1, 2, 3a, 3b and 3c; Ketterlinus et al., 1993) . In addition, X-ray diffraction studies in several picornaviruses, poliovirus (type 1 and 3; Hogle et at., 1985; Filman et aL, 1989) , human rhinovirus 14 (HRV14; Rossmann et al., 1985) , FMDV (Acharya et al., 1989) and Mengovirus (Luo et al., 1987) have been described, and prominent features likely to be recognized by antibodies have been identified.
A virus presents a complex array of antigenic determinants to the immune system of the infected host. Analysis of this antigenic structure, with particular emphasis on the neutralizing determinants, is essential for understanding the molecular details of viral pathogenesis and epidemiology and for designing effective vaccines. Additionally, a thorough description of viral antigenic structure is valuable for the study of viral morphogenesis and virus-host cell interactions.
In this paper, we identify the location of antigenic sites on the surface of SVDV using neutralizing MAbs and neutralization-resistant mutants. In order to confirm the distribution of each antigenic site on the surface of the virion, a three-dimensional structural computer model was built by homology modelling using the poliovirus and rhinovirus co-ordinates obtained from the Protein Data Bank (PDB).
Methods
Cells and virus. IBRS-2 cells were used for all virus propagation, The cells were grown in MEM supplemented with 5 % calf serum and 0.14% NaHCO 3. For virus purification, the virus was propagated in MEM without calf serum. The H/3'76 strain of SVDV (Kodama et al., 1980a, b) was used for MAb preparation and neutralization-resistant mutant selection. The mutants were plaque-purified twice and grown in IBRS-2 cell monolayers in roller bottles.
Virus purification. Virus was purified for MAb preparation and genomic RNA purification. Infected cells were harvested 16 h postinfection when most of the cells exhibited CPE. Virus was purified by a modification of the procedure described by Nomoto et al. (1979) .
Briefly, the clarified infected culture medium was made up to 2 % Sarkosyl and 20 mM-disodium EDTA and centrifuged for 2 h at 60000g and 5°C. The pellet was suspended in 0-05M-Tri~HCI pH 7-4, 0"3 M-NaC1, 1 mM-disodium EDTA and 1% Sarkosyl, and the suspension was sedimented through 30% glycerol containing 0"3 MNaC1, 0-01 M-Tri~HC1 pH7.4, 1 mM-disodium EDTA and 1% Sarkosyl for 2 h at 95000g and 5 °C. The pellet was resuspended in TNE (0.01 M-Tris-HC1 pH 7-4, 0.1 M-NaCI, 1 mM-disodium EDTA) and banded by isopycnic centrifugation in CsC1 (p = 1.34 g/ml) for 16 h at 150000g and 7 °C.
Production of neutralizing MAbs. MAbs were prepared as described previously (Ferguson et aL, 1984) . Eight-week-old BALB/c mice were inoculated intraperitoneally or subcutaneously at 2 week intervals for 4 weeks with 10 to 15 gg of purified SVDV. Hybridomas were screened by neutralization of the H/3'76 strain and cloned by the limiting dilution method. The MAbs were taken from supernatants of hybridoma culture or ascites of mice. The MAbs were isotyped by peroxidase-based ELISA using an Ig subtyping kit (Zymed). Neutralization titres of MAbs were determined by 50% plaque reduction assay.
Selection of neutralization-resistant mutants. Neutralization-resistant mutants were selected using eight neutralizing MAbs. Tenfold serial dilutions of virus (H/3'76) were made in 96-well tissue culture plates. These were mixed with an equal volume of hybridoma superuatant or ascites fluid dilution containing more than 100-fold excess of antibody above endpoint titres, as determined in 50% plaque reduction neutralization tests. For each MAb, four to eight rows of virus dilutions were used. After incubation for 1 h at 37 °C, IBRS-2 cells were added and the plates kept for 3 days at 37 °C. More than three mutants were selected from independent wells for each MAb. The wells were selected from the highest dilutions with virus growth and the mutant virus was plaque-purified twice.
Plaque formation. Plaque assays were used for virus neutralization tests and virus mutant selection. Viruses were inoculated onto 1-dayold IBRS-2 cell monolayers in 60 mm tissue culture plates and allowed to adsorb for 1 h at 37 °C. The monolayers were then overlaid with 5 ml of YLE medium containing 0"86% Noble agar and incubated for 3 days at 37 °C in 5% CO 2. Monolayers were fixed and stained with staining solution coutaining 5% formalin and 0-1% crystal violet in PBS.
Analysis of neutralization resistance by stab-neutralization. For
analysis of the neutralization resistance of the mutants, we devised a stab-neutralization method (SNM). Briefly, IBRS-2 cell monolayers in 60 mm culture plates were overlaid with agar medium containing each MAb or without MAb as a control. A sterilized toothpick was dipped in virus samples and stabbed into the agar plate. After incubation for 2 days at 37 °C, the cells were stained and the diameter of the CPE was compared to that of the control. Neutralization resistance was defined as positive when the diameter was more than 50 % of the control; weak positive was set at 50 % to 25 % of the control and negative at less than 25 %. To standardize the SNM we compared results using different MAb titres added to the agar overlay, different virus titres and using different tools for inoculation.
cDNA cloning of viral RNA. Neutralization-resistant mutants were grown in IBRS-2 cells and purified. Viral RNA was obtained from the purified virus by the method of Grubman et aL (1979) with several modifications. The purified virus was treated with 1% SDS and extracted with phenol~:hloroform. The extracted RNA was recovered by precipitation in ethanol. Double-stranded cDNAs covering the structural protein-coding region were synthesized from purified viral RNA with synthetic oligonucleotide primer, avian myeloblastosis virus reverse transcriptase and DNA polymerase I. Some cDNAs were amplified by RT-PCR. The cDNAs were cloned into the pUC plasmid or M13 phage vector.
cDNA sequencing of escape mutants. The sequence of the structural protein-coding region was determined by the primer extension dideoxynucleotide method. The primers were designed from the sequence data of SVDV (Inoue et aL, 1989) . When carrying out cDNA synthesis using RT-PCR, three individual tubes were used to synthesize and sequence the same region in order to distinguish the mutation of genomic RNA from reading errors introduced by Taq polymerase.
Modelling of three-dimensional structure of SVDV capsid protein.
When building a model of the SVDV protein, we first searched the PDB for homologous proteins of which the three-dimensional structures are known. Among these, only those of poliovirus and HRV 14 (PDB entry codes 2PLV and 4RHV, respectively) showed significant sequence similarity with the SVDV protein. Thus we used these two protein structures as templates for modelling the structure of the SVDV protein. We followed a procedure termed homology modelling (Blundell et al., 1988) , which was implemented from the modelling software SYBYL (Tripos Associates). We first aligned the amino acid sequence of SVDV capsid protein with those of poliovirus and HRV14. The amino acid sequence similarity of SVDV with these proteins was between 50 and 70 %. Based on the sequence and structural similarities, we determined the structurally-conserved regions in the templates and constructed them on a graphics workstation. These regions usually fall into the protein core. The loops connecting them are exposed on the surface and are structurally more flexible. These loops were constructed by the loop search method, in which the PDB is searched for fragments that fit into both ends of the core chains, and by selecting the one which does not cause severe steric hindrance with other parts of the structure. Then the amino acid side chains were built according to the sequence. Finally, the whole structure was energy minimized to remove possible steric hindrances among side chains. ascites and these were 1019 to 103.9 times higher than that of hybridoma culture medium.
Results

Characterization of murine MAbs to SVDV
Neutralization resistance of the mutants
The neutralization resistance of each mutant was examined by SNM with the eight MAbs. The test was duplicated and the results are shown in Fig. 1 . The results determined by this qualitative method were quite reproducible and differences were detected in only six out of 296 experiments (2%). An example of one of the results (27Fll) is presented in Fig. 3 . Ten mutants showed almost the same size of CPE as seen in the control plate and were designated as neutralization resistant. The mutants were separated into five groups by resistance pattern, and each was resistant only to one group of MAbs. These results indicated that the eight MAbs could be divided into five groups and each group recognized an independent neutralization antigenic site. Mutants selected with 27Fll were the exception, and showed resistance only to this MAb, not to the others of the same group.
Selection of neutralization-resistant mutants
The harvested viruses were plaque-purified and a total of 37 mutants was obtained. Mutants were obtained by selection with the MAbs and were named according to the MAb used followed by the letter R and a serial number (Fig. 1) .
Standardization of SNM
In order to standardize the SNM, the tools for inoculation, neutralization titres of the MAb and infective titres of the mutants were examined. IBRS-2 cell monolayers overlaid with agar medium were inoculated with a serial 10-fold dilution of parent virus by stabbing with a toothpick or microtip. When using the microtip, 1 ~tl of sample was inoculated. As toothpick inoculation showed a constant size and a smooth circular shaped CPE, toothpicks were employed for inoculation in all further studies. To determine the optimum neutralization titre of MAb for agar overlay and infectivity of virus inoculation, parental and a mutant virus (3H02-R1) were diluted in a serial 10-fold dilution and inoculated by the stab method onto cell monolayers covered with agar medium containing various neutralization titres of MAb (3H02). Parental virus did not show CPE using a neutralization titre of 100. However, the CPE of the 3H02-R1 mutant at this titre was almost the same size as that observed in the MAbnegative plate (Fig. 2) . Following these results, MAbs were added at a neutralization titre of 100 and viruses were used without dilution (between 10 ~1 and 108.3 TCID~o/ml ) for further study.
Location of amino acid substitutions in the neutralization-resistant mutants
Two to four mutants were used for sequence analysis in each MAb-selected group. From the results of sequencing of the structural protein-coding region, the presence of a single amino acid substitution could be detected in the mutants except 3H02-R1 (Table 2 ). 3H02-R1 had three amino acid substitutions. As one of the three substitutions, amino acid number 2163, was identical to the other mutant selected with the same MAb, the mutation at this position was considered significant. Amino acid substitutions in mutants selected with 3H02 and 6H07 were separated by nine residues in VP2. But there was no cross-resistance by SNM. Mutants selected with 14El0 and 23F10, which were in the same group by SNM, had amino acid substitutions in VP2 (positions 2070 and 2233) and VP3 (3073 and 3076). In a similar manner, mutants in the last group (27Fll, 30B09 and 31D06) had substitutions in VP1 (1272 and 1275) and VP3 (3060). Mutants selected with 27Fll showed amino acid substitution only at 1275 (Thr to Ala) and were resistant only to 27Fll but 31D06-R1, which had a substitution at the same residue (Thr to Pro), was resistant to all of the MAbs in the group.
Distribution of antigenic sites in the three-dimensional structure model
The positions of amino acid substitutions in the mutants were shown as spheres on the three-dimensional structure model of SVDV (Fig. 4a) . Amino acid substitutions in the same group by SNM formed a cluster. Mutations at positions 1087 and 1088 were located close to the fivefold axis of symmetry. Amino acid residues 2070, 2233, 3073 and 3076 were substituted in mutants of the same group and formed a broad cluster at the peripheral area (at the threefold axis) of the pentamer. However, amino acid residues 2154 and 2163, located close to each other, were identified as independent antigenic sites by SNM. The identified substitutions were exposed to the outer surface of the virus capsid in the pentamer model (Fig. 5) . CPE area was compared between the two plates and judged for neutralization resistance. Several viruses in the MAb-positive plate show similar size of CPE to the plate without MAb, and they were judged to be neutralization-resistant mutants.
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Discussion
Neutralization sites of poliovirus and rhinovirus have been precisely analysed using neutralization-resistant mutants. Analysis of neutralization resistance has been performed using the neutralization test or the plaque inhibition method. SNM had the advantage of needing only 5 ml of diluted MAb (final neutralization titre 100). Moreover, there was no necessity to adjust the infectivity of the mutants for the neutralization test. This method therefore gives a great saving in time and cost. Most neutralizing MAbs we obtained were IgM, despite using a standard protocol for preparation of MAbs. It seemed that the population of neutralizing IgM is much higher than that of IgG even at such a late stage. F r o m sequence analysis o f the n e u t r a l i z a t i o n -r e s i s t a n t m u t a n t s , n u c l e o t i d e m u t a t i o n s causing o n e significant amino acid substitution were detected in the structural protein region in each mutant, and the substituted amino acid residue was considered as an important part of the antigenic site recognized by the MAb.
T a b l e 2. Location of amino acid substitutions of neutralization-resistant mutants
The SVDV capsid is assumed to be composed of a mosaic of 60 triads of four viral proteins (VP1, 2, 3 and 4) as in other picornaviruses. VP4 protein is located in the inner capsid. Each of the protein domains except VP4 is based on a fl-sheet organization (Harrison, 1990) ; two sets of four fi-strands form two sheets (BIDG and CHEF). Each fl-strand is joined with loops to give a wedge-like appearance. The loops and N-and C-terminal extensions have a variable size and structure in different picornaviruses. A neutralization site may be formed in the loop or the terminal extensions exposed to the outer surface of the virion as reported for other picornaviruses. All of the 11 amino acid residues identified in this study were located on loops or N-or C-terminal extensions.
The antigenic site including amino acid residues 1087 and 1088 was designated as site 1 in SVDV, and the residues were identified at the upper side of the protomer near the fivefold axis in the three-dimensional model ( Fig. 4a; Fig. 5 ). This site corresponded to the neutralization site of other picornaviruses (e.g. poliovirus site 1; rhinovirus Nim 1A) and was located in the BC loop of VP1. The BC loop possesses a major neutralization site in picornaviruses due to its prominence. As a synthetic peptide of SVDV including the site 1 amino acid residues could elicit neutralizing antibody in an immunization test (data not shown), the site is considered to be a sequential epitope.
Sites 2a and 2b of SVDV, which were located in the EF loop of VP2 at the back of the barrel, were considered to belong to independent antigenic sites from the neutralization test, whereas they corresponded to one site (site 2) in poliovirus (Minor et al., 1986; Page et al., 1988; Wiegers et al., 1990) .
Site 3a (residues 1272, 1275 and 3060) was composed by two structural proteins and the residues formed a cluster on the surface of the model ( Fig. 4a; Fig. 5 ). These residues were located in the C terminus of VP1 and N terminus of VP3. This site is identical to site 3a of poliovirus (Minor et al., 1986; Page et al., 1988; Wiegers & Dernick, 1992) . The mutants selected with 27Fll showed a substitution of Thr to Ala at residue 1275 and were resistant only to MAb 27F11, while 30D06-R1 had a Pro substitution at the same residue and was resistant to all MAbs in the same group (Table 2; Fig. 1 ). It has been observed that different amino acid substitutions at the same residue cause different conformational changes and so show differing resistance to MAb (Page et al., 1988; Uhlig et al., 1990) . In the case of residue 1275, conformational changes caused by the substitution to Pro were greater than those caused by Ala.
Site 3b was also composed by two proteins, the BC loop of VP2 (position 2070) and VP3 (3073 and 3076) and the HI loop of VP2 (2233), and was located near the threefold axis. All of the residues were exposed on the outer surface of the model. The cluster of amino acid residues was estimated to be too broad for the size of a single antibody-binding site ( Fig. 4a; Fig. 5) . A broad distribution of amino acid residues in site 3b has also been reported in poliovirus (Page et al., 1988) and is suspected to span two pentamers at the boundary. In the case of site 3b of SVDV, it is also suspected to be formed from residues 3073, 3076 and 2233 of one pentamer and 2070 from the adjacent pentamer; these residues in adjacent pentamers are closer (approximately 1.0 to 2-7 nm) than to other residues in the same pentamer (approximately 1-9 to 3.4 nm; Fig. 4b ). In poliovirus type 1, the corresponding residue to 2233 is considered to form an independent antigenic site, site 3c, but the MAb used for analysis of this site was obtained from immunization of type 2 virus (Uhlig et al., 1990) . A recent study showed neutralization-resistant mutants selected with MAbs to poliovirus type 1 had amino acid substitutions in site 3b and 3c (Wiegers & Dernick, 1992) . Our results on SVDV confirm these findings.
In this study, we defined five independent neutralization sites on SVDV and have confirmed their location and exposure in a three-dimensional model of protein structure. These results are useful to define the antigenicity of field isolates of SVDV, and also possibly to assist in the development of a synthesized or chimeric vaccine.
